149 related articles for article (PubMed ID: 38597453)
21.
Yan P; He Y; Xie K; Kong S; Zhao W
PeerJ; 2018; 6():e6092. PubMed ID: 30568862
[TBL] [Abstract][Full Text] [Related]
22. Identification of Potential Diagnostic and Prognostic Biomarkers for Gastric Cancer Based on Bioinformatic Analysis.
Niu X; Ren L; Hu A; Zhang S; Qi H
Front Genet; 2022; 13():862105. PubMed ID: 35368700
[No Abstract] [Full Text] [Related]
23. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
24. Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer.
Wang S; Yang X; Liu C; Hu J; Yan M; Ding C; Fu Y
Medicine (Baltimore); 2023 Oct; 102(40):e35111. PubMed ID: 37800754
[TBL] [Abstract][Full Text] [Related]
25. Identification of potential core genes in gastric cancer using bioinformatics analysis.
Shao C; Wang R; Kong D; Gao Q; Xu C
J Gastrointest Oncol; 2021 Oct; 12(5):2109-2122. PubMed ID: 34790378
[TBL] [Abstract][Full Text] [Related]
26. Integrated bioinformatics analysis for exploring hub genes and related mechanisms affecting the progression of gastric cancer.
Wang Y; Li D; Li D; Wang H; Wu Y
Biotechnol Genet Eng Rev; 2023 May; ():1-12. PubMed ID: 37243583
[TBL] [Abstract][Full Text] [Related]
27. Extracellular Matrix-Related Hubs Genes Have Adverse Effects on Gastric Adenocarcinoma Prognosis Based on Bioinformatics Analysis.
Alatan H; Chen Y; Zhou J; Wang L
Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356118
[TBL] [Abstract][Full Text] [Related]
28. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
[TBL] [Abstract][Full Text] [Related]
29. Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis.
Chong X; Peng R; Sun Y; Zhang L; Zhang Z
Biomed Res Int; 2020; 2020():7658230. PubMed ID: 33015179
[TBL] [Abstract][Full Text] [Related]
30. Screening key genes and biomarkers in gastrointestinal metaplasia that progress to gastric cancer by integrated bioinformatics analysis.
Pang L; Yan X; Su D
J Physiol Pharmacol; 2021 Dec; 72(6):. PubMed ID: 35485356
[TBL] [Abstract][Full Text] [Related]
31. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis.
Fei HJ; Chen SC; Zhang JY; Li SY; Zhang LL; Chen YY; Chang CX; Xu CM
Int J Oncol; 2018 Mar; 52(3):955-966. PubMed ID: 29328368
[TBL] [Abstract][Full Text] [Related]
32. Identification of candidate biomarkers associated with gastric cancer prognosis based on an integrated bioinformatics analysis.
Liu Y; Wang DX; Wan XJ; Meng XH
J Gastrointest Oncol; 2022 Aug; 13(4):1690-1700. PubMed ID: 36092336
[TBL] [Abstract][Full Text] [Related]
33. Common Core Genes Play Vital Roles in Gastric Cancer With Different Stages.
Yu Z; Liang C; Tu H; Qiu S; Dong X; Zhang Y; Ma C; Li P
Front Genet; 2022; 13():881948. PubMed ID: 35938042
[No Abstract] [Full Text] [Related]
34. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of gastric cancer-associated gene signatures: Evidence based on a meta-analysis using integrated bioinformatics methods.
Wang J; Gao P; Song Y; Sun J; Chen X; Yu H; Wang Y; Wang Z
J Cell Mol Med; 2018 Nov; 22(11):5743-5747. PubMed ID: 30133128
[TBL] [Abstract][Full Text] [Related]
36. Screening and Survival Analysis of Hub Genes in Gastric Cancer Based on Bioinformatics.
Zheng S; Yang L; Dai Y; Jiang L; Wei Y; Wen H; Xu Y
J Comput Biol; 2019 Nov; 26(11):1316-1325. PubMed ID: 31233344
[No Abstract] [Full Text] [Related]
37. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatic analysis of potential hub genes in gastric adenocarcinoma.
Liu H; Qu Y; Zhou H; Zheng Z; Zhao J; Zhang J
Sci Prog; 2021; 104(1):368504211004260. PubMed ID: 33788653
[TBL] [Abstract][Full Text] [Related]
39. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
[TBL] [Abstract][Full Text] [Related]
40. Hub genes and pathways in gastric cancer: A comparison between studies that used normal tissues adjacent to the tumour and studies that used healthy tissues as calibrator.
Sadegh K; Ahmadi A
IET Syst Biol; 2023 Jun; 17(3):131-141. PubMed ID: 37118990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
